FDA inspection
Baxalta US Incorporated: FDA inspection ending Nov 7, 2025
FDA inspection 1287588 · No Action Indicated (NAI) · Los Angeles, CA
Key facts
| Inspection ID | 1287588 |
|---|---|
| Firm | Baxalta US Incorporated |
| FEI number | 2011021 |
| Address | 4501 Colorado Blvd |
| City | Los Angeles |
| State | CA |
| ZIP | 90039 |
| Country | United States |
| Fiscal year | 2026 |
| Inspection end date | Nov 7, 2025 |
| Classification | No Action Indicated (NAI) |
| Project area | Blood and Blood Products |
| Product type | Biologics |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data